GNIP Peptide | 45-684P

GNIP Peptide | 45-684P | Gentaur UK, US & Europe Distribution

Short Description: GNIP / TRIM7 Peptide

Species: Human

Location: GNIP peptide corresponds to 13 amino acids of GNIP.

Tested Application: Bl

Application: GNIP Peptide is used for blocking the activity of GNIP antibody (catalog number 45-684). The GNIP antibody ships at 0.5 mg/mL and the GNIP Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: GNIP peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: TRIM7

Alternate Names: GNIP, RNF90, GNIP, Tripartite motif-containing protein 7, Glycogenin-interacting protein,

NCBI Gene ID: 81786

User Note: N/A

NCBI Official Name: Tripartite Motif Containing 7

Background: N/A

Disclaimer: This product is for research use only.